![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 13
Zeitschriftenartikel
Müller-Peltzer, K.; Figueiredo, G. Negrao de; Fischereder, M.; Habicht, A.; Ruebenthaler, J. und Clevert, D.-A.
(2018):
Contrast-enhanced ultrasound (CEUS) as a new technique to characterize suspected renal transplant malignancies in renal transplant patients in comparison to standard imaging modalities.
In: Clinical Hemorheology and Microcirculation, Bd. 69, Nr. 1-2: S. 69-75
Müller-Peltzer, K.; Figueiredo, G. Negrao de; Fischereder, M.; Habicht, A.; Ruebenthaler, J. und Clevert, D-A
(2018):
Vascular rejection in renal transplant: Diagnostic value of contrast-enhanced ultrasound (CEUS) compared to biopsy.
In: Clinical Hemorheology and Microcirculation, Bd. 69, Nr. 1-2: S. 77-82
Müller-Peltzer, K.; Rübenthaler, J.; Fischereder, M.; Habicht, A.; Reiser, M. und Clevert, Dirk-André
(2017):
The diagnostic value of contrast-enhanced ultrasound (CEUS) as a new technique for imaging of vascular complications in renal transplants compared to standard imaging modalities.
In: Clinical Hemorheology and Microcirculation, Bd. 67, Nr. 43193: S. 407-413
Hoppe, J.; Holderied, A.; Schäfer, H.; Schönermarck, U.; Anders, H. J. und Fischereder, M.
(2017):
Drug-induced cytochrome-p450 induction as therapy for calcineurin inhibitor intoxication.
In: Transplant international, Bd. 30: S. 33
Fischereder, M.; Habicht, A.; Stangl, M. und Müller, S.
(2017):
Expression of PD-L1 in Squamous Carcinoma of the Skin of Renal Transplant Recipients.
In: Transplant international, Bd. 30: S. 30
Fischereder, M.; Friedrich, S.; Klingmüller, U.; Kauke, T.; Breidenbach, T.; Bösebeck, D.; Angelika, E.; Cohen, C.; Banas, B.; Guba, M.; Stangl, M.; Krämer, B.; Hugo, C.; Lopau, K.; Stadtler, M. und Mone, T.
(2017):
A Mutation of the Erythropoietin Receptor Correlates with Improved Function of Deceased-Donor Renal Transplants.
In: American Journal of Transplantation, Bd. 17: S. 360
Naik, M.; Arns, W.; Basic, E.; Budde, K.; Diekmann, F.; Fischereder, M.; Gossmann, J.; Gwinner, W.; Heller, K.; Heyne, N.; Jürgensen, J. S.; Morath, C. und Riester, U.
(2017):
Patient And Graft Survival In Patients With Previous Malignancies After Conversion MTOR Inhibitor Sirolimus In A Large German Cohort.
In: Transplant international, Bd. 30: S. 33-34
Schönermarck, U.; Dengler, C.; Gmeinwieser, A.; Praun, S.; Schelling, Gustav; Fischereder, M.; Boulesteix, Anne-Laure und Dolch, M. E.
(2016):
Exhaled breath volatile organic and inorganic compound composition in end-stage renal disease.
In: Clinical Nephrology, Bd. 86, Nr. 9: S. 132-140
Scherbaum, C. R. und Fischereder, M.
(2016):
Diabetes und Dialyse.
In: Diabetologe, Bd. 12, Nr. 3: S. 209-217
Stumpp, J.; Rau, S.; Werner, J.; Meiser, B.; Andrassy, J.; Fischereder, M.; Stangl, M. und Habicht, A.
(2016):
INDUCTION THERAPY IN LOW-RISK RENAL ALLOGRAFT RECIPIENTS - CAN WE SPARE IT TO AVOID INFECTIOUS COMPLICATIONS?
In: Transplant international, Bd. 29: S. 27
Sauter, M.; Sigl, J.; Schotten, Klaus-Jürgen; Kreuzer, L.; Gunthner-Biller, M. und Fischereder, M.
(2015):
Use of oestrogen-containing medication is not associated with renal angiomyolipoma in tuberous sclerosis: findings from a survey.
In: International Urology and Nephrology, Bd. 47, Nr. 4: S. 707-708
Andrassy, J.; Hoffmann, V. S.; Rentsch, M.; Stangl, M.; Habicht, A.; Meiser, B.; Fischereder, M.; Jauch, Karl-Walter und Guba, M.
(2012):
Is Cytomegalovirus Prophylaxis Dispensable in Patients Receiving an mTOR Inhibitor-Based Immunosuppression? A Systematic Review and Meta-Analysis.
In: Transplantation, Bd. 94, Nr. 12: S. 1208-1217
Hoffmann, U.; Banas, B.; Fischereder, M. und Kramer, B. K.
(2004):
N-acetylcysteine in the prevention of radiocontrast-induced nephropathy: Clinical trials and end points.
In: Kidney & Blood Pressure Research, Nr. 3: S. 161-166
[PDF, 99kB]